[go: up one dir, main page]

FI932552A7 - Menetelmä säädellyn vapautumisen kiinteän yksikköannostusmuodon valmis tamiseksi - Google Patents

Menetelmä säädellyn vapautumisen kiinteän yksikköannostusmuodon valmis tamiseksi Download PDF

Info

Publication number
FI932552A7
FI932552A7 FI932552A FI932552A FI932552A7 FI 932552 A7 FI932552 A7 FI 932552A7 FI 932552 A FI932552 A FI 932552A FI 932552 A FI932552 A FI 932552A FI 932552 A7 FI932552 A7 FI 932552A7
Authority
FI
Finland
Prior art keywords
preparing
dosage form
controlled release
unit dosage
solid unit
Prior art date
Application number
FI932552A
Other languages
English (en)
Swedish (sv)
Other versions
FI932552A0 (fi
FI932552L (fi
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of FI932552A7 publication Critical patent/FI932552A7/fi
Publication of FI932552A0 publication Critical patent/FI932552A0/fi
Publication of FI932552L publication Critical patent/FI932552L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
FI932552A 1990-12-07 1991-12-03 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen FI932552L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form
PCT/SE1991/000813 WO1992010169A1 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form

Publications (3)

Publication Number Publication Date
FI932552A7 true FI932552A7 (fi) 1993-06-04
FI932552A0 FI932552A0 (fi) 1993-06-04
FI932552L FI932552L (fi) 1993-06-04

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932552A FI932552L (fi) 1990-12-07 1991-12-03 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen

Country Status (20)

Country Link
US (1) US5419918A (fi)
EP (1) EP0560822B1 (fi)
JP (1) JP3239319B2 (fi)
AT (1) ATE130188T1 (fi)
AU (1) AU659114B2 (fi)
CA (1) CA2097175A1 (fi)
DE (1) DE69114721T2 (fi)
DK (1) DK0560822T3 (fi)
ES (1) ES2079689T3 (fi)
FI (1) FI932552L (fi)
GR (1) GR3018685T3 (fi)
HU (1) HUT64212A (fi)
IE (1) IE914229A1 (fi)
IS (1) IS3789A7 (fi)
NO (1) NO932054D0 (fi)
PL (1) PL168605B1 (fi)
PT (1) PT99721A (fi)
SE (1) SE9003904D0 (fi)
WO (1) WO1992010169A1 (fi)
YU (1) YU182091A (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ291495B6 (cs) * 1992-09-18 2003-03-12 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelotvorný farmaceutický přípravek s prodlouženým uvolňováním
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IN186245B (fi) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
CA2909370A1 (en) * 2013-04-16 2014-10-23 Murray And Poole Enterprises Limited Sustained-release formulations of colchicine and methods of using same
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
EP0149186B1 (en) * 1983-12-20 1988-03-16 Tosoh Corporation Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
DE69114721T2 (de) 1996-04-18
WO1992010169A1 (en) 1992-06-25
HU9301672D0 (en) 1993-09-28
YU182091A (sh) 1994-04-05
FI932552A0 (fi) 1993-06-04
PL299376A1 (en) 1994-03-07
JP3239319B2 (ja) 2001-12-17
HUT64212A (en) 1993-12-28
EP0560822B1 (en) 1995-11-15
CA2097175A1 (en) 1992-06-08
AU659114B2 (en) 1995-05-11
PL168605B1 (pl) 1996-03-29
EP0560822A1 (en) 1993-09-22
JPH06503310A (ja) 1994-04-14
DE69114721D1 (de) 1995-12-21
GR3018685T3 (en) 1996-04-30
NO932054L (no) 1993-06-04
FI932552L (fi) 1993-06-04
IE914229A1 (en) 1992-06-17
ES2079689T3 (es) 1996-01-16
AU8930991A (en) 1992-07-08
IS3789A7 (is) 1992-06-08
US5419918A (en) 1995-05-30
SE9003904D0 (sv) 1990-12-07
NO932054D0 (no) 1993-06-04
PT99721A (pt) 1993-04-30
ATE130188T1 (de) 1995-12-15
DK0560822T3 (da) 1996-03-11

Similar Documents

Publication Publication Date Title
FI20031888L (fi) Menetelmä hallitusti vapautuvan oksikodoniannosmuodon valmistamiseksi
FI870588A7 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
FI914398A7 (fi) Menetelmä farmaseuttisen kokoonpanon valmistamiseksi
FI914354L (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
FI905683L (fi) Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi
FI885884L (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI906249A7 (fi) Menetelmä farmaseuttisen seoksen valmistamiseksi
FI921021A7 (fi) Menetelmä trans-Pt(IV)-yhdisteiden valmistamiseksi
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI932552A7 (fi) Menetelmä säädellyn vapautumisen kiinteän yksikköannostusmuodon valmis tamiseksi
FI921174L (fi) Menetelmä metyylieetterien valmistamiseksi
FI912109A7 (fi) Menetelmä polymeerikoostumuksen valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI911131L (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
FI940280L (fi) Menetelmä demetyyliepypodofyylilotoksiinin valmistamiseksi
FI20001776A7 (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI923498A7 (fi) Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI913554L (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
FI873407L (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
FI911420L (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
NO922637L (no) Fremgangsmaate for fremstilling av en kornforfinende tilsats
FI935019L (fi) Menetelmä klodronaattivalmisteen valmistamiseksi
FI923360A7 (fi) Menetelmä dimetyyliasetoasetamidin valmistamiseksi
FI910366L (fi) Menetelmä deoksimulundokandiinin valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed